Determining Responses to Two Different Vaccines in HIV and HCV Infected Individuals

Completed · Phase 1

Conditions studied: HIV Infections, Hepatitis C

In brief

Infection with either HIV or hepatitis C virus (HCV) affects immune system responses. The purpose of this study is to investigate the immune responses to two different vaccine formulations in HIV-infected, HCV-infected, and HCV/HIV- coinfected individuals.

Key facts

Study ID

NCT00393276

Run by

National Institute of Allergy and Infectious Diseases (NIAID)

People needed

29

Starts

2007-08-01

Expected to finish

2009-07-01

Last updated by the study team

2021-11-01

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

Where it is running

• UCSD Antiviral Research Center CRS — San Diego, California, United States
• Ucsf Aids Crs — San Francisco, California, United States
• University of Colorado Hospital CRS — Aurora, Colorado, United States
• IHV Baltimore Treatment CRS — Baltimore, Maryland, United States
• Massachusetts General Hospital Clinical Research Site (MGH CRS) CRS — Boston, Massachusetts, United States
• Columbia P&S CRS — New York, New York, United States
• Duke Univ. Med. Ctr. Adult CRS — Durham, North Carolina, United States
• Case CRS — Cleveland, Ohio, United States
• MetroHealth CRS — Cleveland, Ohio, United States
• The Ohio State University Medical Center — Columbus, Ohio, United States
• Trinity Health and Wellness Center CRS — Dallas, Texas, United States
• Puerto Rico AIDS Clinical Trials Unit CRS — San Juan, Puerto Rico

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.